Home › Funds › Intellectus Partners, LLC › ABCL

Intellectus Partners, LLC position in ABCL

ABCELLERA BIOLOGICS INC · Health Care

Intellectus Partners, LLC reported holding 584,133 shares of ABCL (ABCELLERA BIOLOGICS INC) in its Q3 2026 13F filing — a position valued at US$8.5M, representing 1.42% of its reported portfolio and ranking #13 among its reported holdings. Intellectus Partners, LLC has disclosed ABCL holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)584.13K sh
Reported value held$8.52M
Portfolio Weight1.42%
First reportedQ3 2023
Last changeAdd
Updated2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

How Intellectus Partners, LLC's ABCL position evolved

Intellectus Partners, LLC first disclosed a stake in ABCL in Q3 2023 at 876,633 shares (US$4.0M). The position peaked in Q3 2026 at 584,133 shares, worth US$8.5M. Across 13 filings, Intellectus Partners, LLC increased the stake 5 time(s), trimmed it 3 time(s) and left it unchanged 4 time(s). The most recent filing (Q3 2026) shows 584,133 shares valued at US$8.5M — an increase of 32,550 shares quarter over quarter.. Notable position changes include a 39% trim in Q1 2024 (shares fell 35% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 876.63K $4.03M New
Q4 2023 887.28K $5.07M Add
Q1 2024 541.78K $2.45M Reduce
Q2 2024 545.53K $1.61M Add
Q3 2024 545.53K $1.42M Hold
Q4 2024 547.53K $1.60M Hold
Q1 2025 548.13K $1.22M Hold
Q2 2025 548.13K $1.88M Hold
Q3 2025 543.13K $2.73M Reduce
Q4 2025 523.38K $1.79M Reduce
Q1 2026 546.08K $1.91M Add
Q2 2026 551.58K $4.33M Add
Q3 2026 584.13K $8.52M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABCL and 13F data

ABCL (ABCELLERA BIOLOGICS INC) is a Health Care company. 41 other funds we track also report a position in ABCL — the largest reported positions include BAKER BROS. ADVISORS LP (US$259.1M), ArrowMark Colorado Holdings LLC (US$32.2M), Guardian Partners Inc. (US$8.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABCL

All ABCL fund holders →

FAQ

How long has Intellectus Partners, LLC held ABCL?

Intellectus Partners, LLC has disclosed ABCL holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Intellectus Partners, LLC's current position in ABCL?

As of Q3 2026, Intellectus Partners, LLC holds 584.13K shares of ABCL (ABCELLERA BIOLOGICS INC), valued at $8.52M, representing 1.42% of its reported portfolio and ranking #13.

Has Intellectus Partners, LLC been buying or selling ABCL?

In the latest 13F filing (Q3 2026), Intellectus Partners, LLC increased its position in ABCL. The position peaked in Q3 2026 at 584.13K shares.

Which other funds hold ABCL?

Other major institutional holders of ABCL include BAKER BROS. ADVISORS LP, ArrowMark Colorado Holdings LLC, Guardian Partners Inc., among 41 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.